Abstract:The cortical distribution and functional role of cholecystokinin (CCK) are largely unknown. Here, a CCK receptor antagonist challenge paradigm was developed to assess functional connectivity and neuronal responses. Structural–functional magnetic resonance imaging and calcium imaging were undertaken in environmental enrichment (EE) and standard environment (SE) groups (naïve adult male mice, n = 59, C57BL/B6J, P = 60). Functional connectivity network-based statistics and pseudo-demarcation Voronoi tessellations to cluster calcium signals were used to derive region of interest metrics based on calcium transients, firing rate, and location. The CCK challenge elicited robust changes to structural–functional networks, decreased neuronal calcium transients, and max firing rate (5 s) of dorsal hippocampus in SE mice. However, the functional changes were not observed in EE mice, while the decreased neuronal calcium transients and max firing rate (5 s) were similar to SE mice. Decreased gray matter alterations were observed in multiple brain regions in the SE group due to CCK challenge, while no effect was observed in the EE group. The networks most affected by CCK challenge in SE included within isocortex, isocortex to olfactory, isocortex to striatum, olfactory to midbrain, and olfactory to thalamus. The EE group did not experience network changes in functional connectivity due to CCK challenge. Interestingly, calcium imaging revealed a significant decrease in transients and max firing rate (5 s) in the dorsal CA1 hippocampus subregion after CCK challenge in EE. Overall, CCK receptor antagonists affected brain-wide structural–functional connectivity within the isocortex, in addition to eliciting decreased neuronal calcium transients and max firing rate (5 s) in CA1 of the hippocampus. Future studies should investigate the CCK functional networks and how these processes affect isocortex modulation. Significance Statement Cholecystokinin is a neuropeptide predominately found in the gastrointestinal system. Albeit abundantly expressed in neurons, the role and distribution of cholecystokinin are largely unknown. Here, we demonstrate cholecystokinin affects brain-wide structural–functional networks within the isocortex. In the hippocampus, the cholecystokinin receptor antagonist challenge decreases neuronal calcium transients and max firing rate (5 s) in CA1. We further demonstrate that mice in environmental enrichment do not experience functional network changes to the CCK receptor antagonist challenge. Environmental enrichment may afford protection to the alterations observed in control mice due to CCK. Our results suggest that cholecystokinin is distributed throughout the brain, interacts in the isocortex, and demonstrates an unexpected functional network stability for enriched mice.

CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens

Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration.

Cholecystokinin octapeptide increases spontaneous glutamatergic synaptic transmission to neurons of the nucleus tractus solitarius centralis

CNS effects of circulating CCK8: involvement of brainstem neurones responding to gastric distension

Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat

Cholecystokinin-dopamine Interactions Within the Nucleus Accumbens in the Control over Behaviour by Conditioned Reinforcement

Cholecystokinin type B receptor-mediated inhibition of A-type K + channels enhances sensory neuronal excitability through the phosphatidylinositol 3-kinase and c-Src-dependent JNK pathway

Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: Evidence for the existence of storage sites containing the two transmitters

Cholecystokinin enhances visceral pain-related affective memory via vagal afferent pathway in rats

Cholecystokinin octapeptide antagonized the effect of NDAP on CaM in rat dorsal spinal synaptosome

Effects of Cholecystokinin Octapeptide and Lesion of the Medial Forebrain Bundle on the Contents of Dopamine and CCK-8 from Ventral Tegmental Area and Nucleus Accumbens

Cholecystokinin receptor antagonist challenge elicits brain-wide functional connectome modulation with micronetwork hippocampal decreased calcium transients

Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor

Cholecystokinin Octapeptide (CCK-8) Antagonizes Morphine Analgesia in Nucleus Accumbens of the Rat Via the CCK-B Receptor

Cholecystokinin Octapeptide Antagonized Opioid Analgesia Mediated by Μ- and Κ- but Not Δ-Receptors in the Spinal Cord of the Rat

Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala

CCK-8 enhances acid-sensing ion channel currents in rat primary sensory neurons

CCK RECEPTOR ANTAGONIST L-365,260 POTENTIATED ELECTROACUPUNCTURE ANALGESIA IN WISTAR RATS BUT NOT IN AUDIOGENIC EPILEPTIC RATS

Cholecystokinin Octapeptide Reverses the Inhibitory Effect Induced by Electroacupuncture on C-Fiber Evoked Discharges

Cholecystokinin-8 and nerve growth factor: two endogenous molecules working for the upkeep and repair of the nervous system

Modification by Cholecystokinin Octapeptide of the Binding of?-, ?-, and <sub>K</sub>-Opioid Receptors